Submission Deadline
02 Dec 2022 (Vol 45 , Iss 10 )

Upcoming Publication
30 Nov 2022 (Vol 45 , Iss 09 )

Journal ID : TMJ-26-01-2022-11044
Download [This article belongs to Volume - 45, Issue - 01]
Total View : 405

Title : Estimation of the IL-6 serum level in the Iraqi newly diagnosed AML patients

Abstract :

Acute Myeloid leukemia (AML) is a cancer that develops quickly and spreads throughout the body in a short amount of time. In Iraq, there are 1674 new cases of leukemia registered in 2018. Interleukin-6 (IL-6) is a multifunctional interleukin which has an important action in AML.A 60 Iraqi individuals (30 newly diagnosed AML patients & 30 controls) have been chosen to estimate their IL-6 level in the serum. We found a significant decrease in IL-6 among AML-study groups than that of control (29.64367 ± 5.237342 vs. 34.76133 ± 3.472883) (t= -4.461, df: 58, P= 0.000) which is may be due to the high level of IL-37 which has a negative correlation with IL-6 in newly diagnosed AML patients. We recommend studying lager number of samples to get more understandings about the role of IL-6 role in newly diagnosed AML.

Full article
//